Product Program year 2025 Source: CMS Open Payments

Alinity m

Device Molecular Diagnostics

PDI 00884999048034

Open in the dashboard

General payments

$3,904,690

673 payments

Research payments

$9,430,185

996 payments

Through program year 2025, $3,904,690 in general payments and $9,430,185 in research payments were reported against Alinity m (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $679,680 283
2025 Research $76,525 2
2024 General $657,577 140
2024 Research $81,645 3
2023 General $2,547,291 200
2023 Research $4,762,758 635
2022 General $17,726 31
2022 Research $10,493 17
2021 General $2,416 19
2021 Research $4,498,764 339

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $3,904,690 673 payments
Top recipients General payments · program year 2025
  1. Stanford Health Care Teaching hospital · CA $247,775 36% · 39 payments
  2. Montefiore Medical Center Teaching hospital · NY $136,582 20% · 6 payments
  3. Langley Porter Psychiatric Hospital Teaching hospital · CA $89,723 13% · 3 payments
  4. The Methodist Hospital Teaching hospital · TX $76,573 11% · 9 payments
  5. Stefan Riedel Clinical Pathology · Baltimore, MD $30,803 5% · 31 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Pathology Pathology $30,803 60% · 1 practitioner
  2. Infectious Disease Internal Medicine $7,187 14% · 7 practitioners
  3. Anatomic Pathology & Clinical Pathology Pathology $4,014 8% · 15 practitioners
  4. Pediatrics $3,926 8% · 1 practitioner
  5. Obstetrics & Gynecology $2,567 5% · 15 practitioners

The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $342,944 50% · 26 recipients
  2. New York $136,868 20% · 9 recipients
  3. Texas $76,589 11% · 2 recipients
  4. Maryland $30,689 5% · 1 recipient
  5. Arizona $27,500 4% · 1 recipient

The top 5 of 25 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

673 general · 996 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record